A case report of fatal anaphylaxis on first exposure to rasburicase just before lymphoma treatment

A case report of fatal anaphylaxis on first exposure to rasburicase just before lymphoma treatment

Abstract Background Rasburicase, a recombinant urate oxidase enzyme, has potent efficacy in controlling uric acid and is widely used to prevent tumor lysis syndrome in high-risk patients owing to its low toxicity profile. However, it has been associated with a risk of anaphylaxis, especially on re-e...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshikazu Utsu, Natsuho Kaneda, Makio Kawakami, Shin-ichi Masuda, Hironori Arai, Sonoko Shimoji, Rena Matsumoto, Takafumi Tsushima, Kazusuke Tanaka, Kosuke Matsuo, Chiharu Kimeda, Shiho Konno, Nobuyuki Aotsuka
Format: Article
Language:English
Published: BMC 2024-10-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Rasburicase
Anaphylaxis
Allergy
Asthma
Initial administration
Lymphoma
Online Access:https://doi.org/10.1186/s13223-024-00920-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13223-024-00920-9

Similar Items